ArticlePharmaceuticals (Basel, Switzerland)2020

Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation.

Julian Wolfes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.